Effect of Recombinant Human Granulocyte Colony –Stimulating Factor for Patients With COVID-19 and Lymphopenia

This randomized clinical trial examines the effect of recombinant human granulocyte colony-stimulating factor on peripheral blood leukocyte and lymphocyte cell counts and clinical improvement in Chinese patients with COVID-19.
Source: JAMA Internal Medicine - Category: Internal Medicine Source Type: research